HomeNewsVideosBusinessMarketsSpecialty portfolio emerges as a strong growth driver over the years

Specialty portfolio emerges as a strong growth driver over the years

Sun Pharma is the largest pharma company of India with about 8.2 percent market share in the domestic formulation industry. It also gets a sizeable revenue from its global specialty business which fetches higher margin than the pharma generic business. Key watch for company in coming months is the progress for Specialty pipeline, the US tariffs on pharma products and expansion of domestic field force. 

March 12, 2025 / 08:05 IST
Story continues below Advertisement

Moneycontrol News
first published: Mar 12, 2025 08:05 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!